The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force

白癜风 一致性 毁容 医学 人口 工作队 疾病 阶段(地层学) 皮肤病科 临床实习 外科 病理 物理疗法 内科学 环境卫生 古生物学 生物 政治学 公共行政
作者
Alain Taı̈eb,Mauro Picardo,on behalf of the other VETF members
出处
期刊:Pigment Cell Research [Wiley]
卷期号:20 (1): 27-35 被引量:494
标识
DOI:10.1111/j.1600-0749.2006.00355.x
摘要

Summary Vitiligo is the most common depigmenting disorder, which affects 0.5–1% of the worldwide population, causing disfigurement and serious disturbances in well being. There is a current lack of consensus in definition and methods of assessment of this disorder, which makes it generally impossible to compare the outcomes of different studies of the same treatment. This report summarizes the work carried out by the Vitiligo European Task Force to propose a consensus definition of the disease and to assess treatment outcomes using a system which combines analysis of extent, stage of disease (staging), and disease progression (spreading). In summary, extent is evaluated using the rule of 9. Staging is based on cutaneous and hair pigmentation in vitiligo patches, and the disease is staged 0–3 (revised version) on the largest macule in each body region, except hands and feet, which are assessed separately and globally as one unique area. Assessment of spreading is based on Wood's lamp examination of the same largest macule in each body area. Wood's lamp is useful for a combined assessment of staging and spreading in the same selected area. This study reports a workshop which validated the clinical use of the assessment form performed at several European University clinics, and showed an overall good concordance among panelists using the proposed scoring system. This system can be easily handled in clinical practice. However, variations between scorer profiles indicate a need for training to decrease interobserver variability. Further steps are envisaged, namely: (i) build a global index including staging and spreading for the initial assessment of vitiligo patients, usable as a guidance for therapeutic indications and prognosis, which could be interpreted as an equivalent of the TNM (tumor, node, metastasis) system for cancer; (ii) implement large‐scale tests necessary for clinical trials (to check reproducibility and sensitivity); (iii) carry out studies of automated devices to assess extent more accurately; (iv) set up a teaching tool for scoring vitiligo, which could be posted on a website; and (v) set up an international conference on classifying, staging and scoring vitiligo, through the IFPCS Special Interest Group on Vitiligo.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
实验室的应助被张张晶晶采纳,获得30
刚刚
刚刚
科研通AI6.2的应助被李雪宁采纳,获得10
1秒前
共享精神的应助被cj采纳,获得10
1秒前
1秒前
2秒前
3秒前
Chris学长完成签到,获得积分10
4秒前
青年才俊发布了新的文献求助10
4秒前
亭亭喜欢大熊猫完成签到,获得积分10
5秒前
5秒前
ding的应助被TTYF采纳,获得10
6秒前
今天禾了吗完成签到,获得积分10
6秒前
净坛使者完成签到,获得积分10
7秒前
邓青坤完成签到 ,获得积分10
7秒前
和谐采珊的应助被QQ糖采纳,获得10
8秒前
夏洳发布了新的文献求助10
8秒前
8秒前
cleff完成签到 ,获得积分10
8秒前
韩维完成签到 ,获得积分10
9秒前
璃粒完成签到,获得积分10
10秒前
慕青的应助被clamon采纳,获得10
12秒前
fantasy的应助被爱做梦的火烈鸟采纳,获得10
12秒前
刘硕发布了新的文献求助10
12秒前
CarryLJR发布了新的文献求助10
12秒前
lmsing发布了新的文献求助20
14秒前
14秒前
李健的小迷弟的应助被黎昕采纳,获得10
15秒前
18秒前
18秒前
19秒前
华仔的应助被今天没带脑子采纳,获得10
19秒前
南檬完成签到,获得积分10
19秒前
20秒前
流浪猫猫完成签到 ,获得积分10
21秒前
KK发布了新的文献求助10
22秒前
小老贾完成签到,获得积分10
22秒前
酷波er的应助被Leexxxhaoo采纳,获得10
23秒前
夏日气泡水完成签到 ,获得积分10
25秒前
wxy完成签到 ,获得积分10
25秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
RNA结合蛋白调控丝状真菌次级代谢的分子机制及功能研究 2000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1080
Encyclopedia of Modern Artificial Intelligence 1000
Особенности технологий и методов информационно-психологических войн СССР с Великобританией и США в период 1939-1953 гг 1000
Critical Psychology 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8145455
求助须知:如何正确求助?哪些是违规求助? 9544400
关于积分的说明 21662647
捐赠科研通 7731415
什么是DOI,文献DOI怎么找? 3422669
关于科研通互助平台的介绍 2547774
邀请新用户注册赠送积分活动 2465502